Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Walawander

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1995
Pretreatment regimens for adverse events related to infusion of amphotericin BS D Goodwin, J D Cleary, C A Walawander, et al.
Journal of Clinical Pharmacology|July 1, 1989
The influence of intravenous cimetidine dosage regimens on the disposition of theophyllineM B Gutfeld, L S Welage, C A Walawander, et al.
Pharmacotherapy|July 1, 1997
Symptomatic cardiotoxicity associated with 5-fluorouracilC C Meyer, K A Calis, L B Burke, et al.
The Annals of Pharmacotherapy|February 1, 1994
Use of antifungal therapy in hospitalized patients. II. Results after the marketing of fluconazoleT H Grasela, M T Pasko, S D Goodwin, et al.
DICP : the Annals of Pharmacotherapy|December 1, 1990
A nationwide survey of antibiotic prescribing patterns and clinical outcomes in patients with bacterial pneumoniaT H Grasela, L S Welage, C A Walawander, et al.
The Annals of Pharmacotherapy|March 1, 1995
Adverse drug reaction reporting in a multicenter surveillance studyE G Timm, L S Welage, C A Walawander, et al.
Pharmacotherapy|January 1, 1989
Prospective surveillance of antibiotic-associated coagulopathy in 970 patientsT H Grasela, C A Walawander, L S Welage, et al.
Pharmacotherapy|January 1, 1995
Sepsis syndrome and associated sequelae in patients at high risk for gram-negative sepsisK Conboy, L S Welage, C A Walawander, et al.
JAMA|September 8, 1993
The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysisW A Knaus, F E Harrell, C J Fisher, et al.
The Journal of Infectious Diseases|June 1, 1994
Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosineT H Grasela, C A Walawander, M Beltangady, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1995
Pretreatment regimens for adverse events related to infusion of amphotericin BS D Goodwin, J D Cleary, C A Walawander, et al.
Journal of Clinical Pharmacology|July 1, 1989
The influence of intravenous cimetidine dosage regimens on the disposition of theophyllineM B Gutfeld, L S Welage, C A Walawander, et al.
Pharmacotherapy|July 1, 1997
Symptomatic cardiotoxicity associated with 5-fluorouracilC C Meyer, K A Calis, L B Burke, et al.
The Annals of Pharmacotherapy|February 1, 1994
Use of antifungal therapy in hospitalized patients. II. Results after the marketing of fluconazoleT H Grasela, M T Pasko, S D Goodwin, et al.
DICP : the Annals of Pharmacotherapy|December 1, 1990
A nationwide survey of antibiotic prescribing patterns and clinical outcomes in patients with bacterial pneumoniaT H Grasela, L S Welage, C A Walawander, et al.
The Annals of Pharmacotherapy|March 1, 1995
Adverse drug reaction reporting in a multicenter surveillance studyE G Timm, L S Welage, C A Walawander, et al.
Pharmacotherapy|January 1, 1989
Prospective surveillance of antibiotic-associated coagulopathy in 970 patientsT H Grasela, C A Walawander, L S Welage, et al.
Pharmacotherapy|January 1, 1995
Sepsis syndrome and associated sequelae in patients at high risk for gram-negative sepsisK Conboy, L S Welage, C A Walawander, et al.
JAMA|September 8, 1993
The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysisW A Knaus, F E Harrell, C J Fisher, et al.
The Journal of Infectious Diseases|June 1, 1994
Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosineT H Grasela, C A Walawander, M Beltangady, et al.
Pageof 3